1. Home
  2. PWP vs EVO Comparison

PWP vs EVO Comparison

Compare PWP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$15.65

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.57

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PWP
EVO
Founded
2006
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
994.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PWP
EVO
Price
$15.65
$2.57
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$23.50
$7.00
AVG Volume (30 Days)
1.3M
28.6K
Earning Date
05-01-2026
04-08-2026
Dividend Yield
1.31%
N/A
EPS Growth
138.52
N/A
EPS
0.02
N/A
Revenue
N/A
N/A
Revenue This Year
$28.86
$1.37
Revenue Next Year
$18.95
$10.05
P/E Ratio
$791.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.54
$2.31
52 Week High
$25.93
$4.42

Technical Indicators

Market Signals
Indicator
PWP
EVO
Relative Strength Index (RSI) 41.29 37.20
Support Level $15.74 $2.32
Resistance Level $19.09 $3.82
Average True Range (ATR) 0.85 0.07
MACD 0.13 -0.03
Stochastic Oscillator 45.25 0.00

Price Performance

Historical Comparison
PWP
EVO

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: